Facial plastic surgery clinics of North America
-
Facial Plast Surg Clin North Am · Feb 2007
ReviewDiagnosis, impact, and management of focal hyperhidrosis: treatment review including botulinum toxin therapy.
Idiopathic localized hyperhidrosis, called for hyperhidrosis, affects almost 3% of the US population. The most frequent anatomic sites of involvement include the axillae, palms, soles, and face. ⋯ Since 1996, intracutaneous injections of botulinum toxin have been used as a minimally invasive treatment for this condition with numerous studies documenting safety, efficacy, and extremely high levels of patient satisfaction. Botulinum toxin type A (Botox) was approved by the US Food and Drug Administration in 2004 for the treatment of axillary hyperhidrosis.